Cite
HARVARD Citation
Shak, S. et al. (n.d.). Breast cancer-specific survival in 6, 768 patients with lymph nodepositive (LN+) hormone receptor-positive (HR+) invasive breast cancer (BC) and 21-gene Recurrence Score® (RS) results in the SEER registries. Breast. pp. S97-S98. [Online].